Curi Bio: Valuation, Funding & Investors
Curi Bio unlocks novel workflows and delivers functional human data to inform biopharmaceutical R&D decision making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and advanced automated data analysis, Curi Bio blends functional and analytical assessments for drug safety, efficacy, and potency.
Leadership & Board
- Current Number of Employees
- 61
- Current LinkedIn Followers
- 11,357
Latest Estimated Valuation
- Total Amount Raised
- $10M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $10M
- Latest Funding Round
- Series B
Company Momentum Positive
Curi Bio LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Curi Bio had 61 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Curi Bio had 11,357 followers as of October 26, 2026. The number of followers increased by 60 (0.53%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 02, 2025 | Series B | $10.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| DreamCIS | Series B |
Similar Companies
A snapshot of private companies similar to Curi Bio, helping you discover and navigate related company profiles.
Related News and Analysis
